2018 is the year gene therapies come into their own. After decades on unfulfilled potential, this space is gaining tangible momentum, particularly in addressing the significant unmet need in a range of rare diseases.

Gene Therapy for Rare Disorders Europe is the uniquely focused conference uniting industry leaders to discuss the late-stage challenges that need to be overcome to deliver more gene therapies to market.

Rather than early stage basic science, this meeting is solely devoted to addressing the latest clinical, manufacturing, regulatory and commercialization challenges facing this rapidly evolving field. This is a comprehensive guide to define your commercial path forward. Visit the website to see the full agenda, speaker line-up, registration costs and more: https://bit.ly/2KoxFys

Claim a special 10% discount when you quote 9709PJ1 at the checkout.

Contact:
+44 (0)20 3141 8700
info@hansonwade.com